Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company’s medicines in this field are undisputed leaders, driving solid top-line growth.
1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November
view original post